Real-world use and 6-month effectiveness of vedolizumab subcutaneous in IBD patients: results of the VEDO-IBD study

被引：0
|
作者：
Plachta-Danielzik, S. [1 ]
Bokemeyer, B. [1 ,2 ,3 ]
Efken, P. [4 ]
Mohl, W. [5 ]
Hoffstadt, M. [6 ]
Krause, T. [7 ]
Schweitzer, A. [8 ]
Schnoy, E. [9 ]
Ehehalt, R. [10 ]
Trentmann, L. [11 ]
Teich, N. [12 ]
Atreya, R. [13 ]
Franzenburg, S. [1 ]
Hartmann, P.
Wenske, T. [1 ]
Schreiber, S. [1 ]
机构：
[1] Competence Network IBD, Study Dept, Kiel, Germany
[2] Interdisciplinary Crohn Colitis Ctr Minden, Crohn Colitis Ctr, Minden, Germany
[3] Univ Hosp Schleswig Holstein Campus Kiel, Clin Gen Internal Med 1, Kiel, Germany
[4] Gastroenterol Practice Minden, Minden, Germany
[5] Ctr Gastroenterol Saar MVZ, Saarbrucken, Germany
[6] Gastroenterol Practice Iserlohn, Iserlohn, Germany
[7] Gastroenterol Practice Kassel, Kassel, Germany
[8] Gastroenterol Practice Muenster, Munster, Germany
[9] Univ Hosp Augsburg, III Med Clin, Augsburg, Germany
[10] Gastroenterol Practice Heidelberg, Heidelberg, Germany
[11] Gastroenterol Practice Bremen, Bremen, Germany
[12] Gastroenterol Practice Leipzig, Leipzig, Germany
[13] Friedrich Alexander Univ Erlangen Nuernberg, Med Clin 1, Erlangen, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P784
引用
收藏
页码：918 / 919
页数：2
相关论文
共 50 条
  • [41] Comparing Real-World use of Dietary and Medical Therapies in Children and Adults with IBD
    Barnett, M.
    Su, W. K.
    Pipicella, J.
    Kaur, H.
    Wilson, W.
    Connor, S. J.
    Andrews, J. M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1775 - i1775
  • [42] Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study
    Nomura, Kei
    Shibuya, Tomoyoshi
    Odakura, Rina
    Haraikawa, Mayuko
    Ishino, Hirotaka
    Orikasa, Masayuki
    Omori, Masashi
    Koma, Masao
    Ito, Kentaro
    Maruyama, Takafumi
    Nomura, Osamu
    Ishikawa, Dai
    Hojo, Mariko
    Nagahara, Akihito
    BIOMEDICINES, 2024, 12 (09)
  • [43] Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia
    Turkoz, Ibrahim
    Wong, Joshua
    Chee, Benjamin
    Siddiqui, Uzma
    Knight, R. Karl
    Richarz, Ute
    Correll, Christoph U.
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2023, 13
  • [44] Early Versus Later Use of Vedolizumab In IBD: Patient Characteristics And Treatment Patterns In The Real World (RALEE)
    Maja, Kuharic
    Noa, Krugliak Cleveland
    Ninfa, Candela
    John, Carter
    Joyce, Qian
    Nifasha, Rusibamayila
    Robin, Turpin
    David, Rubin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S11 - S11
  • [45] Effectiveness of vedolizumab on intestinal outcomes and articular manifestations: Real-world data from the Sicilian Network for inflammatory bowel disease (SN-IBD)
    Macaluso, F. S.
    Orlando, R.
    Fries, W.
    Scolaro, M.
    Magnano, A.
    Pluchino, D.
    Cappello, M.
    Morreale, G. C.
    Siringo, S.
    Privitera, A. C.
    Ferracane, C.
    Belluardo, N.
    Alberghina, N.
    Ventimiglia, M.
    Rizzuto, G.
    Renna, S.
    Cottone, M.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S436 - S437
  • [46] Real-world clinical outcomes after elective discontinuation of first-use biologics in IBD patients
    Shivaji, U. N.
    Bazarova, A.
    Critchlow, T.
    Nardone, O. M.
    Smith, S. C.
    Love, M.
    Davis, J.
    Ghosh, S.
    Iacucci, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S395 - S396
  • [47] Real-world quality of life experience of subcutaneous infliximab use in children with Inflammatory Bowel Disease (IBD) at a tertiary paediatric centre
    Dutt, S.
    Chidgey, T.
    Chuah, C. W.
    Eldredge, J.
    Magoffin, A.
    Puppi, J.
    Siew, S.
    Singh, N.
    Stormon, M.
    Tano, M.
    Thacker, K.
    O'Loughlin, E. V.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2163 - i2163
  • [48] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE & LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): 6-MONTH ANALYSIS RESULTS
    Giorgino, F.
    Guerci, B.
    Garcia-Perez, L. E.
    Boye, K.
    Aigner, U.
    Heitmann, E.
    Federici, Orsini M.
    Zimner-Rapuch, S.
    Rosilio, M.
    Norrbacka, K.
    Sapin, H.
    VALUE IN HEALTH, 2020, 23 : S506 - S506
  • [49] Maintenance phase effectiveness and persistence after two years in biologic-naive ulcerative colitis patients treated with vedolizumab or anti-TNF (VEDO-IBD-study)
    Plachta-Danielzik, S.
    Bokemeyer, B.
    Efken, P.
    Mohl, W.
    Krause, T.
    Hoffstadt, M.
    Ehehalt, R.
    Trentmann, L.
    Schweitzer, A.
    Jessen, P.
    Franzenburg, S.
    Hartmann, P.
    di Giuseppe, R.
    Schreiber, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 933 - 934
  • [50] REAL-WORLD EXPERIENCE FOR BIOLOGIC USE IN IBD IN THAI: A SINGLE-CENTER EXPERIENCE
    Limsrivilai, Julajak
    Chaemsupaphan, Thanaboon
    Sattayalertyanyong, Onuma
    Subdee, Nichcha
    Permpim, Parinya
    Pausawasdi, Nonthalee
    GASTROENTEROLOGY, 2023, 164 (04) : S69 - S69
12345